Search
01/03/2025
Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting: The SPRING study
Puig L., Daudén E., Cuervas-Mons M., Novella C., Guisado C.. Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting: The SPRING study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39DOI:10.1111/jdv.19403. PMID:37567861. IF:8.000(Q1/1D).
01/06/2024
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient's Perspective: A Systematic Review
Armario-Hita JC, Carrascosa JM, Flórez Á, Herranz P, Pereyra-Rodríguez JJ, Serra-Baldrich E, Silvestre JF, Comellas M, Isidoro O, Ortiz de Frutos FJ. Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient's Perspective: A Systematic Review. Dermatitis. 2024; 35(3)DOI:10.1089/derm.2023.0163. PMID:37751176. IF:3.200(Q1/2D).
01/05/2024
Drainage setons for the management of sinus tracts in hidradenitis suppurativa.
Vilarrasa E, Camiña-Conforto G, Cabo F, Fernández-Vela J, Pousa M, Romaní J. Drainage setons for the management of sinus tracts in hidradenitis suppurativa.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(5)DOI:10.1016/j.jaad.2023.08.058. PMID:37634739. IF:11.800(Q1/1D).
02/04/2024
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
Mateu-Arrom, LL, Puig, LL. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities. Expert Review of Clinical Pharmacology. 2024; 17(4)DOI:10.1080/17512433.2024.2340552. PMID:38603464. IF:3.000(Q2/4D).
01/04/2024
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
Daudén, E, Escario, E, Martos-Cabrera, L, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera, R, de la Cueva, P, Martorell, A, Ballesca, F, Belinchón, I, Carretero, G, Rodríguez, L, Romero-Maté, A, Pujol-Montcusí, J, Salgado, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandrés, O, Feltes, R, Riera-Monroig, J, Garrido, J, Llamas-Velasco, M. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(4)DOI:10.1111/ijd.16915. PMID:38168847. IF:3.200(Q1/3D).
12/02/2024
Gluteal hidradenitis suppurativa: analysis of 83 patients [Hidradenitis supurativa con afectación glútea: análisis de 83 pacientes]
Martí NR, Vilarrasa E, Llunell CL, Gamissans M, Sin M, Romaní J. Gluteal hidradenitis suppurativa: analysis of 83 patients [Hidradenitis supurativa con afectación glútea: análisis de 83 pacientes]. Actas Dermo-Sifiliograficas. 2024; 115(2)DOI:10.1016/j.ad.2023.09.021. PMID:37797882. IF:(Q/D).